Pharma Synthesis

Conduct Research

• The Greening of Pharma
  the common issues all members face and how we can work together precompetitively and noncompetitively to solve them.? More specifically, Cue says, the two big issues the Roundtable is tackling are 1) the development of metrics that would help pharma companies answer the question, How do we measure how...
• Will Pharma Wear the Energy Star?
  performance leaders. EPA and Argonne National Laboratories are developing the pharma EPIs, based on drug manufacturing plant data collected by the U.S. Census Bureau and Department of Energy. The model is in its early draft form, and is under review by energy professionals from participating...
• A Synthesis of Cultures
  . Digital Insights. Therapeutic Dose. Community. Login. On Pharma Blog. Twitter. LinkedIn. Facebook. YouTube. Calendar of Events. E-News. Experts. Webcasts. Magazine. Current issue. Issue Archive. Training & Cert. Subscribe. A Synthesis of Cultures. When executives at Samchully Pharmaceuticals Co. Ltd...
• Tuning in to New Solvents
  . RSS. Contact Us. Advertise. All. Articles. White Papers. Products. News. Member Login. Become a Member. Home. Topics. Aseptic Processing. Automation & Control. cGMPs Compliance. Contract Manufacturing. Drug Delivery. Facilities & Support. Facility of the Future. Fill Finish. Focus on Pharma Podcast...
• Drug Development Through the Looking Glass
  reinvent the wheel. ?Although many synthetic tools are available for introducing chirality in the laboratory, the challenge is to perform these reactions on industrial scale,? says Ronald Gebhard, Ph.D., R&D director at DSM Pharma Chemicals (Geleen, Netherlands). When asymmetric synthesis...
• When Less is Much, Much More
  . According to CEO Dirk Kirschnek, Ph.D., fine chemical companies often turn to microtechnology for process intensification and greater plant efficiency, while pharmaceutical companies seek more efficient production and higher yield due to the high value of pharma intermediates. Moreover, processes...
• Contract Research in China: A Catalyst for Pharmaceutical Industry Growth
  By Yibing Zhou, BioPlan Associates, Inc. Since the regulatory and business climate began to improve in the late 1990s, global CROs have begun to establish a presence in China. In 1996, MDS Pharma Services first set up a branch company in Beijing, becoming the first foreign-based CRO to operate...
• Tuning in to New Solvents
  , such processes have already been applied in a host of other applications, and in each case they give superior products and cost benefits. GSK, Pall Speed Microbiological Contamination Detection The Desired State: PAT and the Road to Enlightenment Online Course on Pharma Project Management Begins Jan. 23...
• Making the Most of Drug Development Data
  development. . This quick, one-time registration gives you access to members-only site benefits. Link to this article from your web site or blog Copyright (C) 2004 -- 2009 Pharma Manufacturing. Processing & Engineering | Making the Most of Drug Development Data | Pharmaceutical Manufacturing. Digital...
• The Third Way for ICH Q7A: A Proposal for Updating Guidance for API Inspections
  production. (Note: Q7A does not apply to steps prior to the introduction of the defined API starting material.) However, in light of recent problems with outsourced APIs and the growing number of small pharma houses, the ability of ICH Guidances to protect consumers. Pharmaceutical Process Analytical...

Engineering Web Search: Pharma Synthesis